1,799 Shares in Axon Enterprise, Inc. (NASDAQ:AXON) Purchased by Plato Investment Management Ltd

Plato Investment Management Ltd acquired a new stake in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,799 shares of the biotechnology company's stock, valued at approximately $529,000.

A number of other large investors have also recently added to or reduced their stakes in the business. ING Groep NV boosted its stake in Axon Enterprise by 9.3% during the fourth quarter. ING Groep NV now owns 9,643 shares of the biotechnology company's stock worth $2,491,000 after buying an additional 821 shares during the period. Avantax Advisory Services Inc. increased its holdings in Axon Enterprise by 0.8% in the 1st quarter. Avantax Advisory Services Inc. now owns 5,302 shares of the biotechnology company's stock valued at $1,659,000 after purchasing an additional 40 shares during the last quarter. GSA Capital Partners LLP acquired a new stake in Axon Enterprise in the 1st quarter valued at approximately $931,000. Sumitomo Mitsui Trust Holdings Inc. raised its position in Axon Enterprise by 14.8% in the first quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 170,376 shares of the biotechnology company's stock valued at $53,307,000 after purchasing an additional 22,013 shares during the period. Finally, Wealth Enhancement Advisory Services LLC lifted its stake in Axon Enterprise by 21.7% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 9,153 shares of the biotechnology company's stock worth $2,693,000 after purchasing an additional 1,634 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, Director Julie A. Cullivan sold 900 shares of Axon Enterprise stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $353.53, for a total transaction of $318,177.00. Following the sale, the director now directly owns 3,653 shares in the company, valued at approximately $1,291,445.09. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CFO Brittany Bagley sold 4,338 shares of the stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $378.95, for a total value of $1,643,885.10. Following the completion of the sale, the chief financial officer now directly owns 98,825 shares of the company's stock, valued at $37,449,733.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Julie A. Cullivan sold 900 shares of Axon Enterprise stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $353.53, for a total transaction of $318,177.00. Following the completion of the transaction, the director now directly owns 3,653 shares in the company, valued at $1,291,445.09. The disclosure for this sale can be found here. In the last quarter, insiders sold 316,981 shares of company stock worth $115,281,744. Corporate insiders own 6.10% of the company's stock.

Axon Enterprise Stock Up 1.6 %

NASDAQ AXON traded up $6.16 during trading on Monday, reaching $385.77. 479,841 shares of the company's stock were exchanged, compared to its average volume of 520,625. The company has a 50 day moving average price of $340.58 and a two-hundred day moving average price of $315.24. The stock has a market cap of $29.15 billion, a P/E ratio of 112.80, a price-to-earnings-growth ratio of 10.30 and a beta of 0.94. Axon Enterprise, Inc. has a 1 year low of $189.12 and a 1 year high of $386.54. The company has a debt-to-equity ratio of 0.35, a quick ratio of 2.52 and a current ratio of 2.88.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share for the quarter, topping the consensus estimate of $1.02 by $0.18. The firm had revenue of $504.00 million during the quarter, compared to analysts' expectations of $478.35 million. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. The firm's revenue was up 34.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.80 earnings per share. On average, equities research analysts anticipate that Axon Enterprise, Inc. will post 1.79 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

AXON has been the subject of a number of research reports. Craig Hallum lifted their price objective on Axon Enterprise from $370.00 to $376.00 and gave the company a "buy" rating in a research note on Wednesday, August 7th. Needham & Company LLC reiterated a "buy" rating and set a $400.00 price target on shares of Axon Enterprise in a research note on Wednesday, August 7th. Barclays raised their price objective on shares of Axon Enterprise from $381.00 to $387.00 and gave the company an "overweight" rating in a research note on Wednesday, August 7th. JMP Securities upped their target price on shares of Axon Enterprise from $375.00 to $430.00 and gave the stock an "outperform" rating in a research note on Thursday. Finally, Bank of America initiated coverage on shares of Axon Enterprise in a research report on Wednesday, July 17th. They issued a "buy" rating and a $380.00 price target for the company. Two investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $365.38.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.